Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development

Saved in:
Bibliographic Details
Published inHaemophilia : the official journal of the World Federation of Hemophilia Vol. 23; no. 3; pp. 350 - 352
Main Author Iorio, A.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.05.2017
Subjects
Hemophilia
Online AccessGet full text

Cover

Author Iorio, A.
Author_xml – sequence: 1
  givenname: A.
  orcidid: 0000-0002-3331-8766
  surname: Iorio
  fullname: Iorio, A.
  email: iorioa@mcmaster.ca
  organization: McMaster University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28220559$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1u1TAQhS1URH9gwQsgS2zoIq0dx46zrKrSIlVCQrCOHHtCXBw72EnRfRcelrncwgIJb2ak-Xw8PueUHMUUgZDXnF1wPJeTgQsueKuekRMulKxqydXRvpe80jVXx-S0lAfGuKiZekGOa13XTMruhPz8BAVMthM10dElBW931M8LVrP6FAtNIzU0g4W4hh1dtiH4MoGjNsU1pxCwLevm8FakS4ZHn7aC4IZTMCtOcbs5LZMP3tAFRVGoULPSyX-daPbl2_4JHyc_-DVl6uARQlpmxF6S56MJBV491TPy5f3N5-u76v7j7Yfrq_vKCilUZRvR1LZmmoHkg2uMVuiK4np0TIwgu1ZKp01nRcu1aY2wWks3WMs4KG21OCPvDrpLTt83KGs_-2IhBBMBf9Nz3TLVKHQT0bf_oA9pyxG363lXs0bzjrdInR8om1MpGcZ-yX42eddz1u8j69GU_ndkyL55UtyGGdxf8k9GCFwegB8-wO7_Sv3d1c1B8hdaWaSK
CitedBy_id crossref_primary_10_1016_j_thromres_2020_12_004
crossref_primary_10_1080_14740338_2019_1574743
crossref_primary_10_1016_j_pcl_2018_01_004
crossref_primary_10_1080_17474086_2018_1419862
crossref_primary_10_1080_14728214_2021_1988073
crossref_primary_10_1111_ejh_12924
crossref_primary_10_1111_hae_13248
crossref_primary_10_1111_jth_13886
crossref_primary_10_1111_hae_13239
crossref_primary_10_1111_hae_13306
crossref_primary_10_1016_j_transci_2018_07_012
crossref_primary_10_1002_pbc_27466
crossref_primary_10_1016_j_transci_2019_08_008
crossref_primary_10_1111_hae_13400
Cites_doi 10.1160/TH12-03-0188
10.1172/JCI81859
10.1111/jth.12828
10.1111/j.1538-7836.2011.04214.x
10.1111/j.1538-7836.2010.03823.x
10.1001/jama.2010.310
10.1002/14651858.CD003429.pub3
10.1001/jama.2012.13444
10.1111/jth.12202
10.1056/NEJMoa1208024
10.1093/ije/dyn179
10.1056/NEJMe1603419
10.1182/blood-2013-10-529974
10.1111/j.1538-7836.2006.01841.x
10.1111/jth.12882
10.1136/bmj.e3863
10.1093/ije/dyr095
10.1016/0197-2456(89)90059-7
10.1056/NEJMoa067659
10.1073/pnas.98.3.831
10.1111/j.1538-7836.2011.04611.x
ContentType Journal Article
Copyright 2017 John Wiley & Sons Ltd
Copyright_xml – notice: 2017 John Wiley & Sons Ltd
DBID NPM
AAYXX
CITATION
7T5
8FD
FR3
H94
P64
RC3
7X8
DOI 10.1111/hae.13176
DatabaseName PubMed
CrossRef
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
AIDS and Cancer Research Abstracts
Genetics Abstracts
Immunology Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2516
EndPage 352
ExternalDocumentID 10_1111_hae_13176
28220559
HAE13176
Genre letter
Letter
Correspondence
GrantInformation_xml – fundername: Pfizer
– fundername: Grifols
– fundername: NovoNordisk
– fundername: Baxalta
– fundername: Biogen Idec
– fundername: Bayer
– fundername: Octapharma
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29I
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EGARE
EJD
EMB
EMK
EMOBN
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
NPM
AAYXX
CITATION
7T5
8FD
FR3
H94
P64
RC3
7X8
ID FETCH-LOGICAL-c3536-c4342c2080e51bd4a86111618fd03fe59755d8a9c3718a7a3c885dbcc01e68c83
IEDL.DBID DR2
ISSN 1351-8216
IngestDate Fri Aug 16 07:47:31 EDT 2024
Thu Oct 10 20:01:05 EDT 2024
Fri Aug 23 03:46:51 EDT 2024
Wed Oct 16 00:58:47 EDT 2024
Sat Aug 24 00:53:49 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3536-c4342c2080e51bd4a86111618fd03fe59755d8a9c3718a7a3c885dbcc01e68c83
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ORCID 0000-0002-3331-8766
PMID 28220559
PQID 1920481917
PQPubID 2045152
PageCount 3
ParticipantIDs proquest_miscellaneous_1870646351
proquest_journals_1920481917
crossref_primary_10_1111_hae_13176
pubmed_primary_28220559
wiley_primary_10_1111_hae_13176_HAE13176
PublicationCentury 2000
PublicationDate May 2017
2017-05-00
20170501
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: May 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle Haemophilia : the official journal of the World Federation of Hemophilia
PublicationTitleAlternate Haemophilia
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 13
2007; 357
2012; 344
1989; 10
2013; 11
2010; 303
2015; 125
2013; 368
2011; 40
2006
2016; 374
2006; 4
2012; 10
2009; 38
2012; 108
2014; 123
2011; 9
2012; 308
2001; 98
2010; 8
2016; 22
e_1_2_2_4_1
e_1_2_2_14_1
e_1_2_2_5_1
e_1_2_2_13_1
e_1_2_2_6_1
e_1_2_2_12_1
e_1_2_2_23_1
e_1_2_2_7_1
e_1_2_2_11_1
e_1_2_2_10_1
e_1_2_2_21_1
e_1_2_2_20_1
e_1_2_2_2_1
e_1_2_2_3_1
e_1_2_2_19_1
e_1_2_2_9_1
e_1_2_2_18_1
e_1_2_2_8_1
e_1_2_2_17_1
e_1_2_2_16_1
e_1_2_2_15_1
Lacroix‐Desmazes S (e_1_2_2_22_1) 2016; 22
References_xml – volume: 22
  start-page: 7
  year: 2016
  article-title: Relevance of regulatory T cells for the control of FVIII‐specific immune responses in hemophilia A
  publication-title: Haemophilia
– volume: 123
  start-page: 317
  year: 2014
  end-page: 25
  article-title: Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
  publication-title: Blood
– volume: 10
  start-page: 359
  year: 2012
  end-page: 67
  article-title: A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management
  publication-title: J Thromb Haemost
– volume: 303
  start-page: 1180
  year: 2010
  end-page: 7
  article-title: Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis
  publication-title: JAMA
– volume: 308
  start-page: 1676
  year: 2012
  end-page: 84
  article-title: Empirical evaluation of very large treatment effects of medical interventions
  publication-title: JAMA
– volume: 125
  start-page: 3766
  year: 2015
  end-page: 81
  article-title: IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII
  publication-title: J Clin Invest
– volume: 9
  start-page: 700
  year: 2011
  end-page: 10
  article-title: A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
  publication-title: J Thromb Haemost
– volume: 98
  start-page: 831
  year: 2001
  end-page: 6
  article-title: Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses
  publication-title: Proc Natl Acad Sci USA
– volume: 374
  start-page: 2087
  year: 2016
  end-page: 9
  article-title: Hemophilia therapy — navigating speed bumps on the innovation highway
  publication-title: N Engl J Med
– start-page: CD003429
  year: 2006
– volume: 13
  start-page: 876
  year: 2015
  end-page: 9
  article-title: Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTH
  publication-title: J Thromb Haemost
– volume: 357
  start-page: 535
  year: 2007
  end-page: 44
  article-title: Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
  publication-title: N Engl J Med
– volume: 40
  start-page: 1280
  year: 2011
  end-page: 91
  article-title: Magnitude of effects in clinical trials published in high‐impact general medical journals
  publication-title: Int J Epidemiol
– volume: 344
  start-page: e3863
  year: 2012
  article-title: Problems of stopping trials early
  publication-title: BMJ
– volume: 38
  start-page: 276
  year: 2009
  end-page: 86
  article-title: Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses?
  publication-title: Int J Epidemiol
– volume: 4
  start-page: 503
  year: 2006
  end-page: 4
  article-title: Are randomized clinical trials the only truth? Not always
  publication-title: J Thromb Haemost
– volume: 13
  start-page: 360
  year: 2015
  end-page: 9
  article-title: Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)
  publication-title: J Thromb Haemost
– volume: 11
  start-page: 1119
  year: 2013
  end-page: 27
  article-title: Randomized, controlled, parallel‐group trial of routine prophylaxis vs. on‐demand treatment with sucrose‐formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)
  publication-title: J Thromb Haemost
– volume: 108
  start-page: 913
  year: 2012
  end-page: 22
  article-title: Efficacy and safety of prophylaxis with once‐weekly BAY 79‐4980 compared with thrice‐weekly rFVIII‐FS in haemophilia A patients. A randomised, active‐controlled, double‐blind study
  publication-title: Thromb Haemost
– volume: 10
  start-page: 209
  year: 1989
  end-page: 21
  article-title: Practical problems in interim analyses, with particular regard to estimation
  publication-title: Control Clin Trials
– volume: 368
  start-page: 231
  year: 2013
  end-page: 9
  article-title: Factor VIII products and inhibitor development in severe hemophilia A
  publication-title: N Engl J Med
– volume: 8
  start-page: 1256
  year: 2010
  end-page: 65
  article-title: Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review
  publication-title: J Thromb Haemost
– ident: e_1_2_2_8_1
  doi: 10.1160/TH12-03-0188
– ident: e_1_2_2_23_1
  doi: 10.1172/JCI81859
– volume: 22
  start-page: 7
  year: 2016
  ident: e_1_2_2_22_1
  article-title: Relevance of regulatory T cells for the control of FVIII‐specific immune responses in hemophilia A
  publication-title: Haemophilia
  contributor:
    fullname: Lacroix‐Desmazes S
– ident: e_1_2_2_7_1
  doi: 10.1111/jth.12828
– ident: e_1_2_2_5_1
  doi: 10.1111/j.1538-7836.2011.04214.x
– ident: e_1_2_2_15_1
  doi: 10.1111/j.1538-7836.2010.03823.x
– ident: e_1_2_2_19_1
  doi: 10.1001/jama.2010.310
– ident: e_1_2_2_2_1
  doi: 10.1002/14651858.CD003429.pub3
– ident: e_1_2_2_12_1
  doi: 10.1001/jama.2012.13444
– ident: e_1_2_2_6_1
  doi: 10.1111/jth.12202
– ident: e_1_2_2_16_1
  doi: 10.1056/NEJMoa1208024
– ident: e_1_2_2_14_1
  doi: 10.1093/ije/dyn179
– ident: e_1_2_2_20_1
  doi: 10.1056/NEJMe1603419
– ident: e_1_2_2_10_1
  doi: 10.1182/blood-2013-10-529974
– ident: e_1_2_2_3_1
  doi: 10.1111/j.1538-7836.2006.01841.x
– ident: e_1_2_2_21_1
  doi: 10.1111/jth.12882
– ident: e_1_2_2_17_1
  doi: 10.1136/bmj.e3863
– ident: e_1_2_2_11_1
  doi: 10.1093/ije/dyr095
– ident: e_1_2_2_18_1
  doi: 10.1016/0197-2456(89)90059-7
– ident: e_1_2_2_4_1
  doi: 10.1056/NEJMoa067659
– ident: e_1_2_2_13_1
  doi: 10.1073/pnas.98.3.831
– ident: e_1_2_2_9_1
  doi: 10.1111/j.1538-7836.2011.04611.x
SSID ssj0013206
Score 2.2977135
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 350
SubjectTerms Hemophilia
Title Research and policy implications of a recently published controlled study in previously untreated haemophilia patients at high risk of inhibitor development
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhae.13176
https://www.ncbi.nlm.nih.gov/pubmed/28220559
https://www.proquest.com/docview/1920481917
https://search.proquest.com/docview/1870646351
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CDqWXvh9ukqKWHnrxsrIelukpNAlLIT2UBnIoGL1MlqZek909NL8lPzYzsr3dtBRKbwLZ6DmaT5pPnwDemcaUhdQ6F4qu5IRK5NZNZV41ysoYS4T9dFH49LOenclP5-p8Bz6Md2F6fYjNgRtZRlqvycCtW24Z-YWNE47ej-S2uSiJznX0pdiKIKR3NekButwUXA-qQsTi2fx51xf9ATDv4tXkcE4ewrexqj3P5PtkvXITf_2biuN_tuURPBiAKDvsZ85j2IntE7h3OoTan8LNyMljtg2sS_LBbL7FP2eLhlmGCya6rcufrBv49YEN7PdLTCbxWjZvWUds4sV6iR-u20Rux1ysz49FRyc6lg36rktmV4wklBlx3qmIeXsxd7jsXLHwi9_0DM5Ojr9-nOXDUw65F0ro3EshC18gPI2KuyCt0dhyzU0TpqKJuKtRKhhbeYG-0pZWeGNUcN5PedTGG_EcdttFG18C05UUsQi8DN7JoKxr6OGjoqh0wxsXXQZvx0Gtu16xox53OtiuOvVzBvvjcNeD0S5rBLuknoMb2AzebLLR3CiGYtuIvVRzigtLRGk8gxf9NNmUQozcKe7QMnifBvvvxdezw-OUePXvn-7B_YIgRSJb7sPu6modDxAQrdzrNPNvAd1bCHk
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkEvvGlDCxjEgUtW69jxOlIvFbRaoNsDaqVeUORX1BVtNuruHuC38GOZcZJlC0JC3Cw5kZ_j-Wx__gbgja70KJNKpSKnJzm-EKmxQ5kWVW5kCCOE_fRQeHKixmfy43l-vgH7_VuYVh9ideBGlhHXazJwOpBes_ILEwYc3Z-6BbfR3AUFbnj_OVu7Q4iRNSkEXaozrjpdIeLxrH696Y3-gJg3EWt0OUf34Utf2ZZp8nWwXNiB-_6bjuP_tuYB3OuwKDtoJ89D2Aj1I7gz6W7bH8OPnpbHTO1ZExWE2XSNgs5mFTMM10z0XJffWNNR7D3rCPCXmIz6tWxas4YIxbPlHD9c1pHfjrlYn6tZQ4c6hnUSr3NmFoxUlBnR3qmIaX0xtbjyXDP_i-L0BM6ODk_fjdMumkPqRC5U6qSQmcsQoYacWy-NVthyxXXlh6IKuLHJc69N4QS6SzMywmmde-vckAelnRZPYbOe1WEHmCqkCJnnI--s9LmxFcU-yrJCVbyywSbwuh_VsmlFO8p-s4PtKmM_J7DXj3fZ2e28RLxLAjq4h03g1SobLY6uUUwdsJdKTlfDEoEaT2C7nSerUoiUO8RNWgJv42j_vfhyfHAYE8_-_dOXcHd8Ojkujz-cfNqFrYwQRuRe7sHm4noZniM-WtgX0Qx-AkQHDJE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxQxFD7UCsWXWm91tNUoPvgyy-a6GXwqbZf10iJioQ_CkNvQxXZ26O4-6G_xx3qSmVm3iiC-BTJDrifnS86XLwCvdKVHTCiVcxmv5PiC58YORV5U0ogQRgj740Xhk1M1ORPvzuX5Brzp78K0-hCrA7doGWm9jgbe-GrNyC9MGFD0fuoW3BYKkW9ERJ_YWgghPawZX6DLNaOqkxWKNJ7Vrzed0R8I8yZgTR5nfBe-9HVtiSZfB8uFHbjvv8k4_mdjdmC7Q6LkoJ0692Aj1Pdh66SLtT-AHz0pj5jakybpB5PpGgGdzCpiCK6Y6Lcuv5GmI9h70tHfLzGZ1GvJtCZNpBPPlnP8cFkndjvmYn2uZk080jGkE3idE7MgUUOZRNJ7LGJaX0wtrjvXxP8iOD2Es_Hx58NJ3r3lkDsuucqd4II5hvg0SGq9MFphyxXVlR_yKuC2RkqvTeE4OkszMtxpLb11bkiD0k7zR7BZz-rwGIgqBA_M05F3VnhpbBVfPmKsUBWtbLAZvOwHtWxayY6y3-pgu8rUzxns9cNddlY7LxHtRvkc3MFm8GKVjfYWgyimDthLJY2BYZxvkmaw206TVSmRkjvELVoGr9Ng_734cnJwnBJP_v3T57D18Whcfnh7-v4p3GERXiTi5R5sLq6XYR_B0cI-S0bwEx_7C0A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Research+and+policy+implications+of+a+recently+published+controlled+study+in+previously+untreated+haemophilia+patients+at+high+risk+of+inhibitor+development&rft.jtitle=Haemophilia+%3A+the+official+journal+of+the+World+Federation+of+Hemophilia&rft.au=Iorio%2C+A&rft.date=2017-05-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1351-8216&rft.eissn=1365-2516&rft.volume=23&rft.issue=3&rft.spage=350&rft_id=info:doi/10.1111%2Fhae.13176&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-8216&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-8216&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-8216&client=summon